Healthcare utilization and costs in children with stable and uncontrolled epilepsy

Epilepsy and Behavior

Volumn 32, Issue , 2014, Pages 135-141

  Cramer, Joyce A ^a,d   Wang, Zhixiao J ^b   Chang, Eunice ^c   Powers, Annette ^b   Copher, Ronda ^b   Cherepanov, Dasha ^c   Broder, Michael S ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EISAI INC   (United States)

^c PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

^d Neuro Ophthalmology of Texas   (United States)

Author keywords

Antiepileptic drugs; Children; Comorbidities; Cost analysis; Economics; Epilepsy; Medical care; Pediatric epilepsy; Seizures

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; CHILD; COMORBIDITY; COST; ECONOMICS; EPILEPSY; FEMALE; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INSURANCE; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UTILIZATION;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; COSTS AND COST ANALYSIS; EPILEPSY; FEMALE; HEALTH SERVICES; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; RETROSPECTIVE STUDIES;

EID: 84894077012     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.01.016     Document Type: Article

References (30)

1. Ronen G.M., Streiner D.L., Verhey L.H., Lach L., Boyle M.H., Cunningham C.E., et al. Disease characteristics and psychosocial factors: explaining the expression of quality of life in childhood epilepsy. Epilepsy Behav 2010, 18(1-2):88-93.
2. IOM (Institute of Medicine) Epilepsy across the spectrum: promoting health and understanding 2012, The National Academies Press, Washington, DC.
3. Hirtz D., Thurman D.J., Gwinn-Hardy K., Mohamed M., Chaudhuri A.R., Zalutsky R. How common are the "common" neurologic disorders?. Neurology 2007, 68(5):326-337.
4. Theodore W.H., Spencer S.S., Wiebe S., Langfitt J.T., Ali A., Shafer P.O., et al. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 2006, 47(10):1700-1722.
5. Zupanc M.L. Update on epilepsy in pediatric patients. Mayo Clin Proc 1996, 71(9):899-916.
6. Modi A.C., Ingerski L.M., Rausch J.R., Glauser T.A. Treatment factors affecting longitudinal quality of life in new onset pediatric epilepsy. J Pediatr Psychol 2011, 36(4):466-475.
7. Argumosa A., Herranz J.L. Childhood epilepsy: a critical review of cost-of-illness studies. Epileptic Disord 2004, 6(1):31-40.
8. Cramer J.A., Wang Z., Li X., Copher R., Powers A. Health care resource utilization and expenditures of epilepsy in pediatric and adult medicaid population. Value Health 2012, 15(4):A143.
9. Cramer J.A., Wang Z.J., Chang E., Powers A., Copher R., Cherepanov D., et al. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Epilepsy Behav 2014, 31:356-362.
10. McDonagh M., Peterson K., Lee N., Thakurta S. Drug class review: antiepileptic drugs for indications other than epilepsy. Update 2 2008, Oregon Health & Sciences University, Portland, Oregon, [http://derp.ohsu.edu/about/final-products.cfm].
11. Davis K.L., Candrilli S.D., Edin H.M. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia 2008, 49(3):446-454.
12. Ettinger A.B., Manjunath R., Candrilli S.D., Davis K.L. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009, 14:324-329.
13. O'Malley A.S., Pham H.H., Schrag D., Wu B., Bach P.B. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care 2007, 45(6):562-570.
14. Hwang W., Weller W., Ireys H., Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff 2001, 20(6):267-278.
15. HCUP Chronic Condition Indicator Healthcare cost and utilization project (HCUP) 2011, Agency for Healthcare Research and Quality, Rockville, MD, [www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp. Accessed September 5, 2012].
16. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
17. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45(6):613-619.
18. Shields W.D. Catastrophic epilepsy in childhood. Epilepsia 2000, 41(Suppl. 2):S2-S6.
19. Sayed Ali M.A., Elliott R.A., Tata L.J. The direct medical costs of epilepsy in children and young people: a population-based study of health resource utilisation. Epilepsy Res 2014.
20. Gaitatzis A., Carroll K., Majeed A.W., Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613-1622.
21. Strine T.W., Kobau R., Chapman D.P., Thurman D.J., Price P., Balluz L.S. Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia 2005, 46:1133-1139.
22. Kobau R., Zahran H., Thurman D.J., Zack M.M., Henry T.R., Schachter S.C., et al. Epilepsy surveillance among adults - 19 states, behavioral risk factor surveillance system. MMWR Surveill Summ 2008, 57(6):1-20.
23. Seidenberg M., Pulsipher D.T., Hermann B. Association of epilepsy and comorbid conditions. Future Neurol 2009, 4:663-668.
24. Begley C.E., Famulari M., Annegers J.F., Lairson D.R., Reynolds T.F., Coan S., et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41(3):342-351.
25. Strzelczyk A., Reese J.P., Dodel R., Hamer H.M. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008, 26(6):463-476.
26. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Qiu Y., Mallett D., Caleo S. Economic burden of epilepsy among the privately insured in the US. Pharmacoeconomics 2010, 28(8):675-685.
27. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Qiu Y., Mallett D., Caleo S. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia 2010, 51(5):838-844.
28. Lu B., Elliott J.O. Beyond seizures and medications: normal activity limitations, social support, and mental health in epilepsy. Epilepsia 2012, 53:e25-e28.
29. Manjunath R., Paradis P.E., Parisé H., Lafeuille M.H., Bowers B., Duh M.S., et al. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Neurology 2012, 79(18):1908-1916.
30. Strzelczyk A., Haag A., Reese J.P., et al. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany. Epilepsy Behav 2013, 27(3):433-438.